SCHEMBL3906362

SCHEMBL3906362

CCCCCCCOC(=O)c1ccc(C=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.68
NPC1 O15118 1/20 0.68
MAPT P10636 1/20 0.68
RAB9A P51151 1/20 0.68
LMNA P02545 4/20 0.59
ESR1 P03372 4/20 0.59
TSHR P16473 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
CYP2D6 P10635 1/20 0.59
MAPK1 P28482 1/20 0.59
NR1H2 P55055 1/20 0.59
RNASEL Q05823 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
STS P08842 6/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
PDE4D Q08499 1/20 0.58
AKR1C4 P17516 1/20 0.55
AKR1C3 P42330 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7721712 1.00 ALDH1A1 (0.68) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL9762364 1.00 ALDH1A1 (0.68) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL3041650 1.00 ALDH1A1 (0.68) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL9097123 0.98 ALDH1A1 (0.65) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL9099239 0.94 ESR1 (0.68) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL8382842 0.92 TDP1 (0.58) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL20464827 0.92 MAPT (0.58) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL11856354 0.89 ALDH1A1 (0.69) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL11866812 0.89 ALDH1A1 (0.69) ALDH1A1NPC1MAPTRAB9ALMNA
SCHEMBL11856349 0.89 ALDH1A1 (0.69) ALDH1A1NPC1MAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7479504-B2 Edg receptor agonists MERCK & CO., INC. (US) 2009-01-20 US disclosed
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed
EP-1470137-A4 EDG RECEPTOR AGONISTS MERCK & CO INC (US) 2005-06-15 EP disclosed
US-20050070506-A1 Selective s1p1/edg1 receptor agonists DOHERTY GEORGE A (US) 2005-03-31 US disclosed
US-20050033055-A1 Edg receptor agonists MERCK SHARP & DOHME CORP. 2005-02-10 US disclosed
EP-1470137-A1 EDG RECEPTOR AGONISTS Merck & Co., Inc. (US) 2004-10-27 EP disclosed
US-20040058894-A1 Selective S1P1/Edg1 receptor agonists DOHERTY GEORGE A (US) 2004-03-25 US disclosed
WO-2003062252-A1 EDG RECEPTOR AGONISTS MERCK & CO., INC. (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070506-A1 Selective s1p1/edg1 receptor agonists S1PR1, S1PR3, S1PR5 ALDH1A1 2315/4885NPC1 812/4885MAPT 4428/4885
US-20040058894-A1 Selective S1P1/Edg1 receptor agonists S1PR1, S1PR3, S1PR2 ALDH1A1 2305/4885NPC1 631/4885MAPT 4203/4885
US-20050033055-A1 Edg receptor agonists EDNRA, EDNRB, GPR65 ALDH1A1 874/4885NPC1 1366/4885MAPT 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.